SSKN
SSKN
NASDAQ · Health Care

Strata Skin Sciences Inc

$0.26
+0.01 (+3.92%)
Financial Highlights (FY 2026)
Revenue
51.91M
Net Income
-15,599,012
Gross Margin
56.8%
Profit Margin
-30.1%
Rev Growth
+3.8%
D/E Ratio
3.06
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 56.8% 56.9% 60.4% 60.4%
Operating Margin -27.6% -24.8% 8.3% 6.6%
Profit Margin -30.1% -28.6% 6.1% 6.4%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 51.91M 49.99M 4.50M 3.54M
Gross Profit 29.51M 28.42M 2.72M 2.14M
Operating Income -14,315,899 -12,409,042 373.5K 235.6K
Net Income -15,599,012 -13,521,247 275.7K 228.3K
Gross Margin 56.8% 56.9% 60.4% 60.4%
Operating Margin -27.6% -24.8% 8.3% 6.6%
Profit Margin -30.1% -28.6% 6.1% 6.4%
Rev Growth +3.8% +3.8% +8.7% -6.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 555.0K 555.0K 2.50M 2.27M
Total Equity 181.6K 181.6K 2.00M 2.12M
D/E Ratio 3.06 3.06 1.25 1.07
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -5,294,078 -4,843,854 439.3K 404.4K
Free Cash Flow 280.3K 178.6K